Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors
Sponsor: University Hospital, Basel, Switzerland
Summary
The study aims to assess the effect of smart watches and continuous glucose measuring devices on cardiovascular risk factors.
Official title: Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors After Cardiac Rehabilitation - A Randomised Controlled Trial: MITIGATE-RF
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-02-07
Completion Date
2025-08
Last Updated
2024-08-14
Healthy Volunteers
No
Interventions
Fitbit Inspire 2
A smartwatch (Fitbit Inspire 2) with its respective app will be worn by the patients in the intervention group for 3 months.
Abbott Freestyle Libre 3
A continuous glucose measuring device (Abbott Freestyle Libre 3) with its respective app will be worn by the patients in the intervention group for 3 months.
Locations (1)
University Hospital Basel
Basel, Switzerland